Answers are grounded in this paper and cite their sources.
This study provides Class III evidence that serum GDF-15 accurately distinguishes patients with mitochondrial diseases from those without them.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: